Is it just our lab or is anyone else not getting much help these days? Not from Indianapolis, Branford, sales rep, anywhere...getting a bad feeling about the future of this company.
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
How do I even get 2.6 s/w? I see people are using it and we weren't even told about it. Still on 2.53.
Read the blog; now thinking I should hold off on scheduling the upgrade if we can't even keep Ti protocols working. 90% of our work is pyrotag sequencing anyway and amplicon protocol may never be developed officially.
Comment
-
Agreed with RCJK.
We had our upgrade 2 wks ago but we haven´t performed any FLX+ yet because one of our CB+ buffer bottles arrived broken, so we had no reagents to run it. We did a Tf run using reg Titanium and it passed. We don´t know when our FLX+ reagents will arrive. Another big mistake: Roche people didn´t mention that we needed sipper tubes and prewash tubes +, even if we are still using reg tit, so we had to improvise. Over all they should not have upgraded our machine till all the reagents and correct plastics were here. We got some prewash tubes + yesterday and should start running this week.
After all that we are really hoping for a better tech support but we shall see...
Comment
-
-
We got it without any customer account:
Originally posted by HMorrison View PostWe have no customer FTP account. Hmm.
Comment
-
Originally posted by Adam Witney View Post
Comment
-
Originally posted by kmcarr View PostTrue, that will get you v 2.6 of the analysis software but not the new versions of the instrument software; those you can only get directly your Roche/454 contacts. HMorrison will should to contact his/her FAS or product rep and rattle their cages, but I understand this is easier said than done. Both our FAS and sales rep have recently left Roche for other companies and we can't get in touch with the supposed new ones. I'll have to politely disagree with RCJK and MissDNA, getting support from Roche as gotten noticeably worse over the past year.
Working on debugging the series of extremely poor runs on my own. Eventually hope to get back to my Illumina and PGM datasets!! My new sig file says "One and only one sequencing platform can be productive at any point in time." Morrison's Law.
Right now, it's the PGM.
Hilary
Comment
-
Well you guys have better lucky in the US. Our FAS has been the same since 09, and has never done much for us. Till beginning of 2011 I had direct contact with Penzberg but they transfered our tech support to Latin America. I hope things improve here because we had a series of meetings to discuss the issue and our FAS is willing to improve but as I said: "we shall see..."
I do like our engineers. They do their best with what they have. If things are bad in the US, is even harder over here.
We are getting a PGM soon. Hopefully tech support will be better.
Comment
-
Originally posted by HMorrison View PostOkay, Roche is now responding--FAS has gotten in touch and there are some possible reasons for our string of failures other than incompetence on our part.
Comment
-
Still no change. I think Roche has decided to stop supporting true amplicon sequencing and amplicon processing pipeline; it isn't cost effective for them.
Is anyone out there actually using the amplicon processing pipeline but us? HMP sequencing centers' pyrotag 'amplicon' sequencing SOP (shotgun library kits and shotgun processing to get amplicon data) hurt us badly...
Comment
Latest Articles
Collapse
-
by seqadmin
The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...-
Channel: Articles
04-22-2024, 07:01 AM -
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Today, 08:47 AM
|
0 responses
11 views
0 likes
|
Last Post
by seqadmin
Today, 08:47 AM
|
||
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
60 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|
||
Started by seqadmin, 04-10-2024, 10:19 PM
|
0 responses
59 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 10:19 PM
|
||
Started by seqadmin, 04-10-2024, 09:21 AM
|
0 responses
54 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 09:21 AM
|
Comment